Papua New Guinea vs Senegal: Share of children with symptoms of a respiratory infection who received antibiotics
Papua New Guinea
32.9%
in 2018
Senegal
32.5%
in 2018
Papua New Guinea rank
124th
Senegal rank
125th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Papua New Guinea
- Senegal
How they compare
Papua New Guinea currently reports 32.9% against 32.5% in Senegal, a difference of 0.4%.
The two have swapped places 1 time across 19 shared years of data; in 2000 it was Senegal ahead.
Papua New Guinea ranks 124th and Senegal ranks 125th of 132 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 43.6% | 10.6% | Senegal |
| 2010s | 32.5% | 45.1% | 12.6% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Papua New Guinea or Senegal?
- Papua New Guinea, at 32.9% against 32.5% in Senegal as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Papua New Guinea and Senegal?
- 0.4%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Senegal?
- 19 years are reported by both, from 2000 to 2018.
- How do Papua New Guinea and Senegal rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Papua New Guinea ranks 124th and Senegal ranks 125th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.